Skip to main content

Table 1 Association between SNHG12 expression levels (ΔCt) and clinical-pathological factors

From: Network analysis of KLF5 targets showing the potential oncogenic role of SNHG12 in colorectal cancer

Characteristics No. of patients (%) SNHG12 (Mean ± SD) p-value
Age (year)
 ≥ 60 67 (60.4) 5.25 ± 2.19 0.953
 < 60 44 (39.6) 5.23 ± 2.27
Gender
 Male 66 (59.5) 5.27 ± 1.97 0.886
 Female 45 (40.5) 5.21 ± 2.54  
Tumor location
 Colon 54 (48.6) 4.95 ± 2.22 0.169
Rectal 57 (51.4) 5.53 ± 2.18  
Diameter (cm)
 > 5 28 (25.2) 5.12 ± 2.19 0.731
 ≤ 5 83 (74.8) 5.29 ± 2.23
Differentiation
 Well 4 (3.6) 4.49 ± 2.04 0.692
 Moderate 87 (78.4) 5.22 ± 2.25
 Poor 20 (18.0) 5.50 ± 2.11
Invasion
 T1 7 (6.3) 6.79 ± 2.49 0.047*
 T2 23 (20.7) 5.41 ± 2.24
 T3 16 (14.4) 5.91 ± 2.61
 T4 65 (58.6) 4.80 ± 1.92
Lymph node metastasis
 N0 57 (51.4) 5.35 ± 2.25 0.253
 N1 31 (27.9) 5.55 ± 2.26
 N2 23 (20.7) 4.58 ± 1.97
Distal metastasis
 M 0 102 (91.9) 5.36 ± 2.20 0.030*
 M 1 9 (8.1) 3.70 ± 1.68  
TNM stage
 I 21 (18.9) 5.56 ± 2.21 0.256
 II 36 (32.4) 5.21 ± 2.30
 III 44 (39.6) 5.41 ± 2.18
 IV 10 (9.0) 3.96 ± 1.78
  1. A smaller ΔCt value indicates higher expression
  2. * p values are significant under 0.05